Evidence map›Paper›PMID 31878178›Full record

ArticleSensors (Basel, Switzerland)2019

Quantification of Neuropeptide Y with Picomolar Sensitivity Enabled by Guided-Mode Resonance Biosensors.

Mohammad G Abdallah, Joseph A Buchanan-Vega, Kyu J Lee, Brett R Wenner, Jeffery W Allen, Monica S Allen, Susanne Gimlin, Debra Wawro Weidanz, Robert Magnusson

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mohammad G AbdallahDepartment of Electrical Engineering, University of Texas Arlington, Arlington, TX 76019, USA.ORCID 0000-0003-4447-2547
Joseph A Buchanan-VegaDepartment of Electrical Engineering, University of Texas Arlington, Arlington, TX 76019, USA.
Kyu J LeeDepartment of Electrical Engineering, University of Texas Arlington, Arlington, TX 76019, USA.
Brett R WennerAir Force Research Laboratory, Sensors Directorate, Wright-Patterson AFB, OH 45433, USA.ORCID 0000-0001-5630-7413
Jeffery W AllenAir Force Research Laboratory, Munitions Directorate, Eglin AFB, FL 32542, USA.
Monica S AllenAir Force Research Laboratory, Munitions Directorate, Eglin AFB, FL 32542, USA.
Susanne GimlinResonant Sensors Incorporated, Arlington, TX 76010, USA.
Debra Wawro WeidanzResonant Sensors Incorporated, Arlington, TX 76010, USA.
Robert MagnussonDepartment of Electrical Engineering, University of Texas Arlington, Arlington, TX 76019, USA.
The University of Texas at Arlington · USEglin Air Force Base · USResonant Sensors (United States) · USUnited States Air Force Research Laboratory · US

Funding

KBRwyle Laboratories FA8075-14-D-0025-0005
6 · The paper itself

Abstract

Assessing levels of neuropeptide Y (NPY) in the human body has many medical uses. Accordingly, we report the quantitative detection of NPY biomarkers applying guided-mode resonance (GMR) biosensor methodology. The label-free sensor operates in the near-infrared spectral region exhibiting distinctive resonance signatures. The interaction of NPY with bioselective molecules on the sensor surface causes spectral shifts that directly identify the binding event without additional processing. In the experiments described here, NPY antibodies are attached to the sensor surface to impart specificity during operation. For the low concentrations of NPY of interest, we apply a sandwich NPY assay in which the sensor-linked anti-NPY molecule binds with NPY that subsequently binds with anti-NPY to close the sandwich. The sandwich assay achieves a detection limit of ~0.1 pM NPY. The photonic sensor methodology applied here enables expeditious high-throughput data acquisition with high sensitivity and specificity. The entire bioreaction is recorded as a function of time, in contrast to label-based methods with single-point detection. The convenient methodology and results reported are significant, as the NPY detection range of 0.1-10 pM demonstrated is useful in important medical circumstances.

Indexed as

Antibodies, ImmobilizedBiomarkersBiosensing TechniquesHumansImmunoassayNeuropeptide YPolymersAntibodies, ImmobilizedBiomarkersNeuropeptide YPolymersbiomarkersguided-mode resonance biosensorneuropeptide Yoptical biosensorsandwich assay

Identifiers

PMID31878178
PMCPMC6982811
OpenAlexW2998346068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.